Molecular pathogenesis of H5 highly pathogenic avian influenza: The role of the haemagglutinin cleavage site motif

Reviews in Medical Virology

Volumn 25, Issue 6, 2015, Pages 406-430

  Luczo, Jasmina M ^a,b   Stambas, John ^b   Durr, Peter A ^a   Michalski, Wojtek P ^a   Bingham, John ^a  

^a CSIRO   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; INFLUENZA VIRUS HEMAGGLUTININ; VIRULENCE FACTOR;

GENE MUTATION; HUMAN; INFLUENZA A (H5N1); INFLUENZA A VIRUS (H5N1); INFLUENZA A VIRUS (H5N2); INFLUENZA A VIRUS (H5N3); MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NONHUMAN; PATHOGENESIS; REVERSE GENETICS; REVIEW; VIRUS ENTRY; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; AVIAN INFLUENZA; CHICKEN; HOST PATHOGEN INTERACTION; METABOLISM; PATHOGENICITY; PATHOLOGY; PROTEIN DEGRADATION; TRANSMISSION; VIROLOGY; ZOONOSIS;

ANIMALS; CHICKENS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; PROTEOLYSIS; VIRULENCE FACTORS; ZOONOSES;

EID: 84947421990     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1846     Document Type: Review

References (176)

1. de Jong JC, Claas ECJ, Webster RG, Lim WL. A pandemic warning? Nature 1997; 389: 554-554. DOI:10.1038/39218.
2. Beare AS, Webster RG. Replication of avian influenza viruses in humans. Archives of Virology 1991; 119: 37-42. DOI:10.1007/BF01314321.
3. Peiris JSM, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. The Lancet 2004; 363: 617-619. DOI:10.1016/S0140-6736(04)15595-5.
4. Tam JS, Influenza A. (H5N1) in Hong Kong: an overview. Vaccine 2002; 20: S77-S81. DOI:10.1016/S0264-410X(02)00137-8.
5. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2015. http://www.who.int/influenza/human_animal_interface/EN_GIP_20150501CumulativeNumberH5N1cases.pdf?ua=1 [3 June 2015].
6. Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012; 486: 420-428. DOI:10.1038/nature10831.
7. Herfst S, Schrauwen EJA, Linster M, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012; 336: 1534-1541. DOI:10.1126/science.1213362.
8. Sutton TC, Finch C, Shao H, et al. Airborne transmission of highly pathogenic H7N1 influenza in ferrets. Journal of Virology 2014; 88: . DOI:10.1128/jvi.02765-13.
9. Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. New England Journal of Medicine 2013; 368: 1888-1897. DOI:10.1056/NEJMoa1304459.
10. Influenza at the human-animal interface: summary and assessment as of 2 October 2014. http://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface:October14.pdf?ua=1 [7 November 2014].
11. Pillai SPS, Pantin-Jackwood M, Suarez DL, Saif YM, Lee CW. Pathobiological characterization of low-pathogenicity H5 avian influenza viruses of diverse origins in chickens, ducks and turkeys. Archives of Virology 2010; 155: 1439-1451. DOI:10.1007/s00705-010-0727-8.
12. Kobayashi Y, Horimoto T, Kawaoka Y, Alexander DJ, Itakura C. Pathological studies of chickens experimentally infected with two highly pathogenic avian influenza viruses. Avian Pathology 1996; 25: 285-304. DOI:10.1080/03079459608419142.
13. Nakamura K, Imada T, Imai K, et al. Pathology of specific-pathogen-free chickens inoculated with H5N1 avian influenza viruses isolated in Japan in 2004. Avian Diseases 2008; 52: 8-13. DOI:10.1637/8027-060607-Reg.
14. Perkins LEL, Swayne DE. Pathobiology of A/chicken/Hong Kong/220/97 (H5N1) avian influenza virus in seven gallinaceous species. Veterinary Pathology 2001; 38: 149-164. DOI:10.1354/vp.38-2-149.
15. Wibawa H, Bingham J, Nuradji H, et al. The pathobiology of two Indonesian H5N1 avian influenza viruses representing different clade 2.1 sublineages in chickens and ducks. Comparative Immunology, Microbiology and Infectious Diseases 2013; 36: 175-191. DOI:10.1016/j.cimid.2012.12.001.
16. Perkins LEL, Swayne DE. Comparative susceptibility of selected avian and mammalian species to a Hong Kong-origin H5N1 high-pathogenicity avian influenza virus. Avian Diseases 2003; 47: 956-967. DOI:10.1637/0005-2086-47.s3.956.
17. Bingham J, Green DJ, Lowther S, et al. Infection studies with two highly pathogenic avian influenza strains (Vietnamese and Indonesian) in Pekin ducks (Anas platyrhynchos), with particular reference to clinical disease, tissue tropism and viral shedding. Avian Pathology 2009; 38: 267-278. DOI:10.1080/03079450903055371.
18. Senne DA, Panigrahy B, Kawaoka Y, et al. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Diseases 1996; 40: 425-437. DOI:10.2307/1592241.
19. World Organisation for Animal Health: Avian Influenza, 7th edn. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 1. World Organisation for Animal Health: Paris, France, 2012; 436-454.
20. Kawaoka Y, Webster RG. Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proceedings of the National Academy of Sciences USA 1988; 85: 324-328. DOI:10.1073/pnas.85.2.324.
21. Bogs J, Veits J, Gohrbandt S, et al. Highly pathogenic H5N1 influenza viruses carry virulence determinants beyond the polybasic hemagglutinin cleavage site. PLoS ONE 2010; 5: e11826. DOI:10.1371/journal.pone.0011826.
22. Horimoto T, Kawaoka Y. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. Journal of Virology 1994; 68: 3120-3128.
23. Ito T, Goto H, Yamamoto E, et al. Generation of a highly pathogenic avian influenza A virus from an avirulent field isolate by passaging in chickens. Journal of Virology 2001; 75: 4439-4443. DOI:10.1128/JVI.75.9.4439-4443.2001.
24. Walker JA, Molloy SS, Thomas G, et al. Sequence specifity of furin, a proprotein-processing endoprotease, for the hemagglutinin of a virulent avian influenza virus. Journal of Virology 1994; 68: 1213-1218.
25. Muramoto Y, Ozaki H, Takada A, et al. Highly pathogenic H5N1 influenza virus causes coagulopathy in chickens. Microbiology and Immunology 2006; 50: 73-81. DOI:10.1111/j.1348-0421.2006.tb03764.x.
26. Bosch FX, Orlich M, Klenk HD, Rott R. The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology 1979; 95: 197-207. DOI:10.1016/0042-6822(79)90414-8.
27. Wood GW, McCauley JW, Bashiruddin JB, Alexander DJ. Deduced amino acid sequences at the haemagglutinin cleavage site of avian influenza A viruses of H5 and H7 subtypes. Archives of Virology 1993; 130: 209-217. DOI:10.1007/BF01319010.
28. Porter AG, Barber C, Carey NH, Hallewell RA, Threlfall G, Emtage JS. Complete nucleotide sequence of an influenza virus haemagglutinin gene from cloned DNA. Nature 1979; 282: 471-477. DOI:10.1038/282471a0.
29. Swayne DE. Understanding the complex pathobiology of high pathogenicity avian influenza viruses in birds. Avian Diseases 2007; 51: 242-249. DOI:10.1637/7763-110706-regr.1.
30. Swayne DE, Suarez DL, Sims LD. Influenza. In Diseases of Poultry, Swayne DE, Glisson JR, McDougald LR, Nolan LK, Suarez DL, Nair V (eds). 13th ed. John Wiley & Sons, Inc.: Ames, Iowa, 2013; 181-218.
31. Webster RG, Yakhno M, Hinshaw VS, Bean WJ, Murti KG. Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology 1978; 84: 268-278. DOI:10.1016/0042-6822(78)90247-7.
32. Suarez DL, Perdue ML, Cox N, et al. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. Journal of Virology 1998; 72: 6678-6688.
33. Schat KA, Bingham J, Butler JM, et al. Role of position 627 of PB2 and the multibasic cleavage site of the hemagglutinin in the virulence of H5N1 avian influenza virus in chickens and ducks. PLoS ONE 2012; 7: e30960. DOI:10.1371/journal.pone.0030960.
34. Gohrbandt S, Veits J, Hundt J, et al. Amino acids adjacent to the haemagglutinin cleavage site are relevant for virulence of avian influenza viruses of subtype H5. Journal of General Virology 2011; 92: 51-59. DOI:10.1099/vir.0.023887-0.
35. International Committee on Taxonomy of Viruses: Family - Orthomyxoviridae. In Virus Taxonomy, King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (eds). 9th ed. Elsevier: London, 2012; 749-761.
36. Desselberger U, Nakajima K, Alfino P, et al. Biochemical evidence that 'new' influenza virus strains in nature may arise by recombination (reassortment). Proceedings of the National Academy Sciences USA 1978; 75: 3341-3345. DOI:10.1073/pnas.75.7.3341.
37. Adams MJ, King AMQ, Carstens EB. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2013). Archives of Virology 2013; 158: 2023-2030. DOI:10.1007/s00705-013-1688-5.
38. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiological Reviews 1992; 56: 152-179.
39. Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nature Reviews Microbiology 2005; 3: 591-600. DOI:10.1038/nrmicro1208.
40. Hause BM, Collin EA, Liu R, et al. Characterization of a novel influenza virus in cattle and swine: proposal for a new genus in the Orthomyxoviridae family. mBio 2014; 5: e00031-00014. DOI:10.1128/mBio.00031-14.
41. Tong S, Zhu X, Li Y, et al. New world bats harbor diverse influenza A viruses. PLoS Pathogens 2013; 9: e1003657. DOI:10.1371/journal.ppat.1003657.
42. Tong S, Li Y, Rivailler P, et al. A distinct lineage of influenza A virus from bats. Proceedings of the National Academy Sciences USA 2012; 109: 4269-4274. DOI:10.1073/pnas.1116200109.
43. Fouchier RAM, Munster V, Wallensten A, et al. Characterization of a novel influenza a virus hemagglutinin subtype (H16) obtained from black-headed gulls. Journal of Virology 2005; 79: 2814-2822. DOI:10.1128/jvi.79.5.2814-2822.2005.
44. Röhm C, Zhou N, Süss J, Mackenzie J, Webster RG. Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes. Virology 1996; 217: 508-516. DOI:10.1006/viro.1996.0145.
45. Kawaoka Y, Yamnikova S, Chambers TM, Lvov DK, Webster RG. Molecular characterization of a new hemagglutinin, subtype H14, of influenza A virus. Virology 1990; 179: 759-767. DOI:10.1016/0042-6822(90)90143-F.
46. Hinshaw VS, Air GM, Gibbs AJ, Graves L, Prescott B, Karunakaran D. Antigenic and genetic characterization of a novel hemagglutinin subtype of influenza A viruses from gulls. Journal of Virology 1982; 42: 865-872.
47. World Health Organization. A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bulletin of the World Health Organization 1980; 58: 585-591.
48. Alexander DJ. Avian influenza - recent developments. The Veterinary Bulletin 1982; 52: 341-359.
49. Hinshaw VS, Webster RG, Turner B. The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl. Canadian Journal of Microbiology 1980; 26: 622-629. DOI:10.1139/m80-108.
50. Alexander DJ. A review of avian influenza in different bird species. Veterinary Microbiology 2000; 74: 3-13. DOI:10.1016/S0378-1135(00)00160-7.
51. Olson SH, Parmley J, Soos C, et al. Sampling strategies and biodiversity of influenza A subtypes in wild birds. PLoS ONE 2014; 9: e90826. DOI:10.1371/journal.pone.0090826.
52. Cross KJ, Burleigh LM, Steinhauer DA. Mechanisms of cell entry by influenza virus. Expert Reviews in Molecular Medicine 2001; 3: 1-18. DOI:10.1017/S1462399401003453.
53. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annual Review of Biochemistry 2000; 69: 531-569. DOI:10.1146/annurev.biochem.69.1.531.
54. Klenk H-D, Wöllert W, Rott R, Scholtissek C. Association of influenza virus proteins with cytoplasmic fractions. Virology 1974; 57: 28-41. DOI:10.1016/0042-6822(74)90105-6.
55. Elder KT, Bye JM, Skehel JJ, Waterfield MD, Smith AE. In vitro synthesis, glycosylation, and membrane insertion of influenza virus haemagglutinin. Virology 1979; 95: 343-350. DOI:10.1016/0042-6822(79)90489-6.
56. Schmidt MFG. Acylation of viral spike glycoproteins: a feature of enveloped RNA viruses. Virology 1982; 116: 327-338. DOI:10.1016/0042-6822(82)90424-x.
57. Copeland CS, Zimmer KP, Wagner KR, Healey GA, Mellman I, Helenius A. Folding, trimerization, and transport are sequential events in the biogenesis of influenza virus hemagglutinin. Cell 1988; 53: 197-209. DOI:10.1016/0092-8674(88)90381-9.
58. Gething M-J, McCammon K, Sambrook J. Expression of wild-type and mutant forms of influenza hemagglutinin: the role of folding in intracellular transport. Cell 1986; 46: 939-950. DOI:10.1016/0092-8674(86)90076-0.
59. Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza at 3Å resolution. Nature 1981; 289: 366-373. DOI:10.1038/289366a0.
60. McCauley J, Bye J, Elder K, et al. Influenza virus haemagglutinin signal sequence. FEBS Letters 1979; 108: 422-426. DOI:10.1016/0014-5793(79)80578-5.
61. Klenk H-D, Rott R, Orlich M, Blödorn J. Activation of influenza A viruses by trypsin treatment. Virology 1975; 68: 426-439. DOI:10.1016/0042-6822(75)90284-6.
62. Laver WG. Separation of two polypeptide chains from the hemagglutinin subunit of influenza virus. Virology 1971; 45: 275-288. DOI:10.1016/0042-6822(71)90134-6.
63. Wiley DC, Skehel JJ, Waterfield M. Evidence from studies with a cross-linking reagent that the haemagglutinin of influenza virus is a trimer. Virology 1977; 79: 446-448. DOI:10.1016/0042-6822(77)90371-3.
64. Rogers GN, Paulson JC. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 1983; 127: 361-373. DOI:10.1016/0042-6822(83)90150-2.
65. Matlin KS, Reggio H, Helenius A, Simons K. Infectious entry pathway of influenza virus in a canine kidney cell line. Journal of Cell Biology 1981; 91: 601-613. DOI:10.1083/jcb.91.3.601.
66. Bullough PA, Hughson FM, Skehel JJ, Wiley DC. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 1994; 371: 37-43. DOI:10.1038/371037a0.
67. Skehel JJ, Bayley PM, Brown EB, et al. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proceedings of the National Academy Sciences USA 1982; 79: 968-972. DOI:10.1073/pnas.79.4.968.
68. Han X, Bushweller JH, Cafiso DS, Tamm LK. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nature Structural Biology 2001; 8: 715-720. DOI:10.1038/90434.
69. Han X, Tamm LK. pH-dependent self-association of influenza hemagglutinin fusion peptides in lipid bilayers. Journal of Molecular Biology 2000; 304: 953-965. DOI:10.1006/jmbi.2000.4251.
70. Martin K, Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. Journal of Virology 1991; 65: 232-244.
71. Li Z, Jiang Y, Jiao P, et al. The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. Journal of Virology 2006; 80: 11115-11123. DOI:10.1128/jvi.00993-06.
72. Kawaoka Y, Naeve CW, Webster RG. Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology 1984; 139: 303-316. DOI:10.1016/0042-6822(84)90376-3.
73. Lee C-W, Swayne DE, Linares JA, Senne DA, Suarez DL. H5N2 avian influenza outbreak in Texas in 2004: the first highly pathogenic strain in the United States in 20years? Journal of Virology 2005; 79: 11412-11421. DOI:10.1128/jvi.79.17.11412-11421.2005.
74. Alexander DJ, Wood G, Banks J. Questions raised by highly pathogenic avian influenza outbreak in Norfolk, England in 1991. In Proceedings of the Joint First Annual Meetings of the National Newcastle Disease and Avian Influenza Laboratories of the European Communities, Alexander DJ (ed): The European Commission: Brussels, Belgium, 1993; 86-90.
75. Garten W, Klenk H-D. Cleavage activation of the influenza virus hemagglutinin and its role in pathogenesis. In Avian Influenza, Klenk HD, Matrosovich MN, Stech J (eds). Volume 27. Monographs in Virology. Karger: Basel, Switzerland, 2008; 156-167.
76. Avian influenza: assessing the pandemic threat. http://www.who.int/influenza/resources/documents/h5n1_assessing_pandemic_threat/en/index.html [27 January 2012].
77. Virgin S. Pathogenesis of viral infection. In Fields Virology, Knipe DM, Howley PM, Griffin DE, et al. (eds). Volume 1. 5th ed. Lippincott Williams & Wilkins: Philadelphia, Pennsylvania, 2007; 327-388.
78. Swayne DE, Beck JR. Experimental study to determine if low-pathogenicity and high-pathogenicity avian influenza viruses can be present in chicken breast and thigh meat following intranasal virus inoculation. Avian Diseases 2005; 49: 81-85. DOI:10.1637/7260-081104R.
79. Shortridge KF, Zhou NN, Guan Y, et al. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 1998; 252: 331-342. DOI:10.1006/viro.1998.9488.
80. Krauss S, Pryor SP, Raven G, et al. Respiratory tract versus cloacal sampling of migratory ducks for influenza A viruses: are both ends relevant? Influenza Other Respiratory 2013; 7: 93-96. DOI:10.1111/j.1750-2659.2012.00359.x.
81. Webster RG, Morita M, Pridgen C, Tumova B. Ortho- and paramyxoviruses from migrating feral ducks: characterization of a new group of influenza A viruses. Journal of General Virology 1976; 32: 217-225. DOI:10.1099/0022-1317-32-2-217.
82. Ellström P, Latorre-Margalef N, Griekspoor P, et al. Sampling for low-pathogenic avian influenza A virus in wild Mallard ducks: oropharyngeal versus cloacal swabbing. Vaccine 2008; 26: 4414-4416. DOI:10.1016/j.vaccine.2008.06.027.
83. Sturm-Ramirez KM, Hulse-Post DJ, Govorkova EA, et al. Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? Journal of Virology 2005; 79: 11269-11279. DOI:10.1128/jvi.79.17.11269-11279.2005.
84. Yamamoto Y, Nakamura K, Kitagawa K, et al. Pathogenesis in Call ducks inoculated intranasally with H5N1 highly pathogenic avian influenza virus and transmission by oral inoculation of infective feathers from an infected Call duck. Avian Diseases 2007; 51: 744-749. DOI:10.1637/0005-2086(2007)51[744:PICDII]2.0.CO;2.
85. Yamamoto Y, Nakamura K, Okamatsu M, Miyazaki A, Yamada M, Mase M. Detecting avian influenza virus (H5N1) in domestic duck feathers. Emerging Infectious Diseases 2008; 14: 1671-1672. DOI:10.3201/eid1410.080415.
86. Yamamoto Y, Nakamura K, Yamada M, Mase M. Persistence of avian influenza virus (H5N1) in feathers detached from bodies of infected domestic ducks. Applied and Environmental Microbiology 2010; 76: 5496-5499. DOI:10.1128/aem.00563-10.
87. Lu JH, Long JX, Jia LJ, et al. Reassortment and modification of hemagglutinin cleavage motif of avian/WSN influenza viruses generated by reverse genetics that correlate with attenuation. Acta Virologica 2006; 50: 243-249.
88. Reperant LA, Rimmelzwaan GF, Kuiken T. Avian influenza viruses in mammals. Revue scientifique et technique (International Office of Epizootics) [Scientific and Technical Review] 2009; 28: 137-159.
89. Nicholls JM, Chan MCW, Chan WY, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nature Medicine 2007; 13: 147-149. DOI:10.1038/nm1529.
90. Prawira Y, Murniati D, Rusli A, et al. Clinical, laboratory, and radiologic characteristcs of confirmed avian influenza (H5N1). The Southeast Asian Journal of Tropical Medicine and Public Health 2012; 43: 877-889.
91. Subbarao K, Klimov A, Katz J, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998; 279: 393-396. DOI:10.1126/science.279.5349.393.
92. Hien TT, Liem NT, Dung NT, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. New England Journal of Medicine 2004; 350: 1179-1188. DOI:10.1056/NEJMoa040419.
93. Yuen KY, Chan PKS, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. The Lancet 1998; 351: 467-471. DOI:10.1016/S0140-6736(98)01182-9.
94. Wu C, Lu X, Wang X, et al. Clinical symptoms, immune factors, and molecular characteristics of an adult male in Shenzhen, China infected with influenza virus H5N1. Journal of Medical Virology 2013; 85: 760-768. DOI:10.1002/jmv.23492.
95. de Jong MD, Cam BV, Qui PT, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. New England Journal of Medicine 2005; 352: 686-691. DOI:10.1056/NEJMoa044307.
96. Perrone LA, Plowden JK, García-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathogens 2008; 4: e1000115. DOI:10.1371/journal.ppat.1000115.
97. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nature Medicine 2006; 12: 1203-1207. DOI:10.1038/nm1477.
98. To K-F, Chan PKS, Chan K-F, et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. Journal of Medical Virology 2001; 63: 242-246. DOI:10.1002/1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-N.
99. Viemann D, Schmolke M, Lueken A, et al. H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response. Journal of Immunology 2011; 186: 164-173. DOI:10.4049/jimmunol.0904170.
100. Teijaro JR, Walsh KB, Cahalan S, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011; 146: 979-990. DOI:10.1016/j.cell.2011.08.015.
101. Burggraaf S, Karpala AJ, Bingham J, et al. H5N1 infection causes rapid mortality and high cytokine levels in chickens compared to ducks. Virus Research 2014; 185: 23-31. DOI:10.1016/j.virusres.2014.03.012.
102. Cornelissen JBWJ, Vervelde L, Post J, Rebel JMJ. Differences in highly pathogenic avian influenza viral pathogenesis and associated early inflammatory response in chickens and ducks. Avian Pathology 2013; 42: 1-18. DOI:10.1080/03079457.2013.807325.
103. Kuribayashi S, Sakoda Y, Kawasaki T, et al. Excessive cytokine response to rapid proliferation of highly pathogenic avian influenza viruses leads to fatal systemic capillary leakage in chickens. PLoS ONE 2013; 8: e68375. DOI:10.1371/journal.pone.0068375.
104. Karpala AJ, Bingham J, Schat KA, et al. Highly pathogenic (H5N1) avian influenza induces an inflammatory T helper type 1 cytokine response in the chicken. Journal of Interferon and Cytokine Research 2011; 31: 393-400. DOI:10.1089/jir.2010.0069.
105. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proceedings of the National Academy Sciences USA 2007; 104: 12479-12481. DOI:10.1073/pnas.0705289104.
106. Rebel JMJ, Peeters B, Fijten H, Post J, Cornelissen J, Vervelde L. Highly pathogenic or low pathogenic avian influenza virus subtype H7N1 infection in chicken lungs: small differences in general acute responses. Veterinary Research 2011; 42: 10. DOI:10.1186/1297-9716-42-10.
107. Schechter I, Berger A. On the size of the active site in proteases. I.. Papain. Biochemical and Biophysical Research Communications 1967; 27: 157-162. DOI:10.1016/s0006-291x(67)80055-x.
108. Rott R, Orlich M, Scholtissek C. Attenuation of pathogenicity of fowl plague virus by recombination with other influenza A viruses nonpathogenic for fowl: nonexclusive dependence of pathogenicity on hemagglutinin and neuraminidase of the virus. Journal of Virology 1976; 19: 54-60.
109. Stech O, Veits J, Weber S, et al. Acquisition of a polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus is not sufficient for immediate transformation into a highly pathogenic strain. Journal of Virology 2009; 83: 5864-5868. DOI:10.1128/jvi.02649-08.
110. Perdue ML. Molecular determinants of pathogenicity for avian influenza viruses. In Avian Influenza, Swayne DE (ed). 1st ed. Blackwell Publishing: Ames, Iowa, 2008; 23-41.
111. Stieneke-Gröber A, Vey M, Angliker H, et al. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO Journal 1992; 11: 2407-2414.
112. Vey M, Orlich M, Adler S, Klenk HD, Rott R, Garten W. Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R. Virology 1992; 188: 408-413. DOI:10.1016/0042-6822(92)90775-k.
113. Kido H, Okumura Y, Takahashi E, et al. Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure. BBA - Proteins and Proteomics 2012; 1824: 186-194. DOI:10.1016/j.bbapap.2011.07.001.
114. Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 1998; 95: 409-417. DOI:10.1016/s0092-8674(00)81771-7.
115. Compans RW. Influenza virus proteins: II. Association with components of the cytoplasm. Virology 1973; 51: 56-70. DOI:10.1016/0042-6822(73)90365-6.
116. Lazarowitz SG, Compans RW, Choppin PW. Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology 1971; 46: 830-843. DOI:10.1016/0042-6822(71)90084-5.
117. Böttcher E, Matrosovich T, Beyerle M, Klenk HD, Garten W, Matrosovich M. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. Journal of Virology 2006; 80: 9896-9898. DOI:10.1128/jvi.01118-06.
118. Garten W, Matrosovich M, Matrosovich T, Eickmann M, Vahhabzadeh A. Cleavage of influenza virus hemagglutinin by host cell proteases. In Options for the Control of Influenza V, Kawaoka Y (ed). Volume 1263. International Congress Series. Elsevier: Amsterdam, Netherlands, 2004; 218-221. DOI:10.1016/j.ics.2004.01.040
119. Lazarowitz SG, Goldberg AR, Choppin PW. Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen. Virology 1973; 56: 172-180. DOI:10.1016/0042-6822(73)90296-1.
120. Gotoh B, Ogasawara T, Toyoda T, Inocencio NM, Hamaguchi M, Nagai Y. An endoprotease homologous to the blood clotting factor X as a determiant of viral tropsim in chick embryo. EMBO Journal 1990; 9: 4189-4195.
121. Kido H, Yokogoshi Y, Sakai K, et al. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. Journal of Biological Chemistry 1992; 267: 13573-13579.
122. Chen Y, Shiota M, Ohuchi M, et al. Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses - purification and characterization. European Journal of Biochemistry 2000; 267: 3189-3197. DOI:10.1046/j.1432-1327.2000.01346.x.
123. Olsen JV, Ong S-E, Mann M. Trypsin cleaves exclusively C-terminal to arginine and lysine residues. Molecular and Cellular Proteomics 2004; 3: 608-614. DOI:10.1074/mcp.T400003-MCP200.
124. Klenk H-D, Garten W. Host cell proteases controlling virus pathogenicity. Trends in Microbiology 1994; 2: 39-43. DOI:10.1016/0966-842x(94)90123-6.
125. Wise RJ, Barr PJ, Wong PA, Kiefer MC, Brake AJ, Kaufman RJ. Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. Proceedings of the National Academy Sciences USA 1990; 87: 9378-9382. DOI:10.1073/pnas.87.23.9378.
126. Creemers JWM, Van de Ven WJM. Furin. In Handbook of Proteolytic Enzymes, Barrett AJ, Rawlings ND, Woessner JF (eds). 1st ed. Academic Press: London, UK, 1998; 346-349.
127. Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. Journal of Biological Chemistry 1992; 267: 16396-16402.
128. Singh Y, Chaudhary VK, Leppla SH. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo. Journal of Biological Chemistry 1989; 264: 19103-19107.
129. Creemers JWM, Siezen RJ, Roebroek AJM, Ayoubi TAY, Huylebroeck D, Vandeven WJM. Modulation of furin-mediated proprotein processing activity by site-directed mutagenesis. Journal of Biological Chemistry 1993; 268: 21826-21834.
130. Henrich S, Cameron A, Bourenkov GP, et al. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nature Structural Biology 2003; 10: 520-526. DOI:10.1038/nsb941.
131. Decha P, Rungrotmongkol T, Intharathep P, et al. Source of high pathogenicity of an avian influenza virus H5N1: why H5 is better cleaved by furin. Biophysical Journal 2008; 95: 128-134. DOI:10.1529/biophysj.107.127456.
132. Guo XL, Li L, Wei DQ, Zhu YS, Chou KC. Cleavage mechanism of the H5N1 hemagglutinin by trypsin and furin. Amino Acids 2008; 35: 375-382. DOI:10.1007/s00726-007-0611-3.
133. Remacle AG, Shiryaev SA, Oh ES, et al. Substrate cleavage analysis of furin and related proprotein convertases - a comparative study. Journal of Biological Chemistry 2008; 283: 20897-20906. DOI:10.1074/jbc.M803762200.
134. Squires RB, Noronha J, Hunt V, et al. Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. Influenza and Other Respiratory Viruses 2012; 6: 404-416. DOI:10.1111/j.1750-2659.2011.00331.x.
135. Soda K, Asakura S, Okamatsu M, Sakoda Y, Kida H. H9N2 influenza virus acquires intravenous pathogenicity on the introduction of a pair of di-basic amino acid residues at the cleavage site of the hemagglutinin and consecutive passages in chickens. Virology Journal 2011; 8: 64. DOI:10.1186/1743-422x-8-64.
136. Monne I, Fusaro A, Nelson MI, et al. Emergence of a highly pathogenic avian influenza virus from a low-pathogenic progenitor. Journal of Virology 2014; 88: 4375-4388. DOI:10.1128/jvi.03181-13.
137. Influenza A cleavage sites. 2014. http://www.offlu.net/fileadmin/home/en/resource-centre/pdf/Influenza_A_Cleavage_Sites.pdf [8 July 2014]
138. Perdue ML, García M, Senne D, Fraire M. Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses. Virus Research 1997; 49: 173-186. DOI:10.1016/S0168-1702(97)01468-8.
139. Domingo E, Sheldon J, Perales C. Viral quasispecies evolution. Microbiology and Molecular Biology Reviews 2012; 76: 159-216. DOI:10.1128/mmbr.05023-11.
140. Drake JW. Rates of spontaneous mutation among RNA viruses. Proceedings of the National Academy Sciences USA 1993; 90: 4171-4175. DOI:10.1073/pnas.90.9.4171.
141. Heaton NS, Sachs D, Chen C-J, Hai R, Palese P. Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proceedings of the National Academy Sciences USA 2013. DOI:10.1073/pnas.1320524110.
142. García M, Crawford JM, Latimer JW, Rivera-Cruz E, Perdue ML. Heterogeneity in the haemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza viruses from Mexico. Journal of General Virology 1996; 77: 1493-1504. DOI:10.1099/0022-1317-77-7-1493.
143. Bashiruddin JB, Gould AR, Westbury HA. Molecular pathotyping of two avian influenza viruses isolated during the Victoria 1976 outbreak. Australian Veterinary Journal 1992; 69: 140-142. DOI:10.1111/j.1751-0813.1992.tb07485.x.
144. Khatchikian D, Orlich M, Rott R. Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus. Nature 1989; 340: 156-157. DOI:10.1038/340156a0.
145. Maurer-Stroh S, Lee R, Gunalan V, Eisenhaber F. The highly pathogenic H7N3 avian influenza strain from July 2012 in Mexico acquired an extended cleavage site through recombination with host 28S rRNA. Virology Journal 2013; 10: 139. DOI:10.1186/1743-422X-10-139.
146. Pasick J, Handel K, Robinson J, et al. Intersegmental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia. Journal of General Virology 2005; 86: 727-731. DOI:10.1099/vir.0.80478-0.
147. Suarez DL, Senne DA, Banks J, et al. Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerging Infectious Diseases 2004; 10: 693-699. DOI:10.3201/eid1004.030396.
148. Orlich M, Gottwald H, Rott R. Non-homologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus. Virology 1994; 204: 462-465. DOI:10.1006/viro.1994.1555.
149. Subbarao K, Chen HL, Swayne D, et al. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 2003; 305: 192-200. DOI:10.1006/viro.2002.1742.
150. Suguitan AL Jr, Marino MP, Desai PD, et al. The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus. Virology 2009; 395: 280-288. DOI:10.1016/j.virol.2009.09.017.
151. Schrauwen EJA, Bestebroer TM, Munster VJ, et al. Insertion of a multibasic cleavage site in the haemagglutinin of human influenza H3N2 virus does not increase pathogenicity in ferrets. Journal of General Virology 2011; 92: 1410-1415. DOI:10.1099/vir.0.030379-0.
152. Schrauwen EJA, Herfst S, Leijten LM, et al. The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. Journal of Virology 2012; 86: 3975-3984. DOI:10.1128/JVI.06828-11.
153. Suguitan AL Jr, Matsuoka Y, Lau Y-F, et al. The multibasic cleavage site of the hemagglutinin of the highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals. Journal of Virology 2012; 86: 2706-2714. DOI:10.1128/jvi.05546-11.
154. Zeng H, Pappas C, Belser JA, et al. Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection. Journal of Virology 2012; 86: 667-678. DOI:10.1128/jvi.06348-11.
155. Wen Z, Wu C, Chen W, et al. Establishment of MDCK stable cell lines expressing TMPRSS2 and MSPL and their applications in propagating influenza vaccine viruses in absence of exogenous trypsin. Biotechnology Research International 2015; 2015: 1-9. DOI:10.1155/2015/402628.
156. Li S, Liu C, Klimov A, et al. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. Journal of Infectious Diseases 1999; 179: 1132-1138. DOI:10.1086/314713.
157. Tian GB, Zhang SH, Li YB, et al. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 2005; 341: 153-162. DOI:10.1016/j.virol.2005.07.011.
158. Tchitchek N, Eisfeld A, Tisoncik-Go J, et al. Specific mutations in H5N1 mainly impact the magnitude and velocity of the host response in mice. BMC Systems Biology 2013; 7: 1-23. DOI:10.1186/1752-0509-7-69.
159. Walker JA, Kawaoka Y. Importance of conserved amino acids at the cleavage site of the haemagglutinin of a virulent avian influenza A virus. Journal of General Virology 1993; 74: 311-314. DOI:10.1099/0022-1317-74-2-311.
160. Horimoto T, Nakayama K, Smeekens SP, Kawaoka Y. Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. Journal of Virology 1994; 68: 6074-6078.
161. Neumann G, Watanabe T, Ito H, et al. Generation of influenza A viruses entirely from cloned cDNAs. Proceedings of the National Academy Sciences USA 1999; 96: 9345-9350. DOI:10.1073/pnas.96.16.9345.
162. Horimoto T, Kawaoka Y. Biologic effects of introducing additional basic amino acid residues into the hemagglutinin cleavage site of a virulent avian influenza virus. Virus Research 1997; 50: 35-40. DOI:10.1016/s0168-1702(97)00050-6.
163. Horimoto T, Ito T, Alexander DJ, Kawaoka Y. Cleavability of hemagglutinin from an extremely virulent strain of avian influenza virus containing a unique cleavage site sequence. Journal of Veterinary Medical Science 1995; 57: 927-930. DOI:10.1292/jvms.57.927.
164. Zhang Y, Sun Y, Sun H, et al. A single amino acid at the hemagglutinin cleavage site contributes to the pathogenicity and neurovirulence of H5N1 influenza virus in mice. Journal of Virology 2012; 86: 6924-6931. DOI:10.1128/jvi.07142-11.
165. Kawaoka Y, Webster RG. Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin. Journal of Virology 1989; 63: 3296-3300.
166. Deshpande KL, Fried VA, Ando M, Webster RG. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates cleavage. Proceedings of the National Academy Sciences USA 1987; 84: 36-40. DOI:10.1073/pnas.84.1.36.
167. Fauci AS, Collins FS. Benefits and risks of influenza research: lessons learned. Science 2012; 336: 1522-1523. DOI:10.1126/science.1224305.
168. Lu JH, Long JX, Shao WX, Wei DP, Liu XF. Generation of attenuated H5N1 and H5N2 subtypes of influenza virus recombinants by reverse genetics system. Wei Sheng Wu Xue Bao [Acta Microbiologica Sinica] 2005; 45: 53-57.
169. Pasquato A, Seidah NG. The H5N1 influenza variant Fujian-like hemagglutinin selected following vaccination exhibits a compromised furin cleavage. Journal of Molecular Neuroscience 2008; 35: 339-343. DOI:10.1007/s12031-008-9052-z.
170. Tang YH, Wu PP, Sun Q, et al. Role of amino acid residues at positions 322 and 329 of hemagglutinin in virulence of H5N1 avian influenza virus. Bing Du Xue Bao [Chinese Journal of Virology] 2008; 24: 340-344.
171. Abt M, de Jonge J, Laue M, Wolff T. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content. Vaccine 2011; 29: 5153-5162. DOI:10.1016/j.vaccine.2011.05.036.
172. Veits J, Weber S, Stech O, et al. Avian influenza virus hemagglutinins H2, H4, H8, and H14 support a highly pathogenic phenotype. Proceedings of the National Academy Sciences USA 2012; 109: 2579-2584. DOI:10.1073/pnas.1109397109.
173. Yoon S-W, Kayali G, Ali MA, Webster RG, Webby RJ, Ducatez MF. A single amino acid at the hemagglutinin cleavage site contributes to the pathogenicity but not the transmission of Egyptian highly pathogenic H5N1 influenza virus in chickens. Journal of Virology 2013; 87: 4786-4788. DOI:10.1128/JVI.03551-12.
174. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006; 22: 195-201. DOI:10.1093/bioinformatics/bti770.
175. Bordoli L, Kiefer F, Arnold K, Benkert P, Battey J, Schwede T. Protein structure homology modeling using SWISS-MODEL workspace. Nature Protocols 2008; 4: 1-13.
176. Biasini M, Bienert S, Waterhouse A, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Research 2014; 42: W252-W258. DOI:10.1093/nar/gku340.